Cita APA

Reggiani, F., Sauta, E., Torricelli, F., Zanetti, E., Tagliavini, E., Santandrea, G., . . . Sancisi, V. (2021). An integrative functional genomics approach reveals EGLN1 as a novel therapeutic target in KRAS mutated lung adenocarcinoma. Mol Cancer.

Chicago Style Citation

Reggiani, Francesca, et al. "An Integrative Functional Genomics Approach Reveals EGLN1 As a Novel Therapeutic Target in KRAS Mutated Lung Adenocarcinoma." Mol Cancer 2021.

Cita MLA

Reggiani, Francesca, et al. "An Integrative Functional Genomics Approach Reveals EGLN1 As a Novel Therapeutic Target in KRAS Mutated Lung Adenocarcinoma." Mol Cancer 2021.